← back to search

Lysiane Richert

AGIR à dom ·
Area of research
Pharmacology · Oncology
Research interest
Research interests include Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, Liver physiology and pathology, and Drug-Induced Hepatotoxicity and Protection.
h-index
38
citations
4,229
works
161
NIH funding
primary concept
email

Recent publications

Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis
Cells 2020cited by 78position: middledoi
Validation of in vitro methods for human cytochrome P450 enzyme induction: Outcome of a multi-laboratory study
Toxicology in Vitro 2019cited by 58position: middledoi
Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study
Toxicological Sciences 2018cited by 308position: middledoi
Three-Dimensional Spheroid Primary Human Hepatocytes in Monoculture and Coculture with Nonparenchymal Cells
Tissue Engineering Part C Methods 2018cited by 89position: lastdoi
Cytochrome P450 Induction and Xeno‐Sensing Receptors Pregnane X Receptor, Constitutive Androstane Receptor, Aryl Hydrocarbon Receptor and Peroxisome Proliferator‐Activated Receptor α at the Crossroads of Toxicokinetics and Toxicodynamics
Basic & Clinical Pharmacology & Toxicology 2018cited by 68position: middledoi
A multicenter assessment of single-cell models aligned to standard measures of cell health for prediction of acute hepatotoxicity
Archives of Toxicology 2016cited by 101position: middledoi
Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes
Toxicology in Vitro 2016cited by 59position: lastdoi
Comparative Proteomic Characterization of 4 Human Liver-Derived Single Cell Culture Models Reveals Significant Variation in the Capacity for Drug Disposition, Bioactivation, and Detoxication
Toxicological Sciences 2015cited by 91position: middledoi
Transcriptomics hit the target: Monitoring of ligand-activated and stress response pathways for chemical testing
Toxicology in Vitro 2015cited by 28position: middledoi
Hepatocyte-based in vitro model for assessment of drug-induced cholestasis
Toxicology and Applied Pharmacology 2013cited by 91position: middledoi
Transcriptomic Hepatotoxicity Signature of Chlorpromazine after Short- and Long-Term Exposure in Primary Human Sandwich Cultures
Drug Metabolism and Disposition 2013cited by 34position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Magnus Ingelman‐Sundberg · Karolinska Institutet5 papers (2015–2020)C. Parmentier · Kaleida Health4 papers (2013–2020) · 4 papers (2016–2020)Philip Hewitt · Merck KGaA, Darmstadt (Germany)4 papers (2013–2016)Christopher E. Goldring · University of Liverpool3 papers (2015–2018)Rowena Sison‐Young · University of Liverpool3 papers (2015–2018)Eliane Alexandre · Université de franche-comté3 papers (2013–2016)Richard Weaver · University of Nottingham2 papers (2015–2016)Germaine L. Truisi · Merck (Germany)2 papers (2013–2015)S Stanzel · Witten/Herdecke University2 papers (2013–2015)Robert Jones · University of Liverpool2 papers (2015–2016)Arno Lukas · EmergenTec (Austria)2 papers (2013–2015) · 2 papers (2018–2019)Philippe Bachellier · University of Padua2 papers (2016–2018)Annette Kopp Schneider · German Cancer Research Center2 papers (2013–2015)Pieter Annaert · KU Leuven2 papers (2013–2016) · 2 papers (2015–2016)Delilah Hendriks · Princess Máxima Center2 papers (2018–2020)Volker M. Lauschke · Karolinska University Hospital2 papers (2016–2018)Tracey Hurrell · Council for Scientific and Industrial Research2 papers (2018–2020)